tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Risinger, 159 are a HOLD (45.56%), 168 are a BUY (48.14%), 22 are a SELL (6.3%).
Analyst David Risinger, carries an average stock price target met ratio of 71.28% that have a potential upside of 33.66% achieved within 337 days. Previously, David Risinger worked at LEERINK.
David Risinger’s has documented 662 price targets and ratings displayed on 40 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ANAB, AnaptysBio.
Analyst best performing recommendations are on BHC (BAUSCH HEALTH COMPANIES).
The best stock recommendation documented was for BHC (BAUSCH HEALTH COMPANIES) at 4/2/2020. The price target of $17 was fulfilled within 7 days with a profit of $3.42 (25.18%) receiving and performance score of 35.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2026
$315
$50.66 (19.16%)
$265
19 days ago
(10-Sep-2026)
6/7 (85.71%)
$60 (23.53%)
115
Buy Since 12-Sep-2025
$303
$38.66 (14.63%)
$298
1 months 9 days ago
(20-Aug-2026)
2/12 (16.67%)
$41.17 (15.72%)
35
Buy Since 09-Dec-2021
$300
$35.66 (13.49%)
$295
1 months 12 days ago
(17-Aug-2026)
14/16 (87.5%)
$49.67 (19.84%)
506
Hold Since 13-Aug-2026
$300
$35.66 (13.49%)
1 months 16 days ago
(13-Aug-2026)
1/2 (50%)
$49.18 (19.61%)
115
Buy Since 23-Jan-2023
$260
$-4.34 (-1.64%)
$235
1 months 19 days ago
(10-Aug-2026)
9/9 (100%)
$12.03 (4.85%)
133
Which stock is David Risinger most bullish on?
Which stock is David Risinger most reserved on?
